Sign in

    Scott McAuley • Paradigm Capital

    Scott McAuley's questions to Profound Medical Corp (PROF) leadership

    Scott McAuley's questions to Profound Medical Corp (PROF) leadership • Q1 2025

    Question

    Scott McAuley from Paradigm Capital requested details on the Q1 capital revenue, asking if it stemmed from new installations or conversions. He also inquired about the availability timeline for the TULSA-PLUS program and the economic structure of the Siemens partnership.

    Answer

    CFO Rashed Dewan clarified that the Q1 capital revenue was generated from two new site installations and one conversion of an existing site. CEO Arun Menawat projected that TULSA-PLUS compatibility and initial deals would be ready by the end of Q3. He explained the goal is to drive TULSA procedure revenue, remaining flexible on how the MRI hardware is sourced. CCO Thomas Tamberrino added that TULSA-PLUS is a comprehensive, customizable program that extends beyond just the magnet to provide a complete 'soup to nuts' solution for launching a TULSA program.

    Ask Fintool Equity Research AI

    Scott McAuley's questions to Profound Medical Corp (PROF) leadership • Q2 2024

    Question

    Scott McAuley of Paradigm Capital sought clarification on the source of the reported capital equipment revenue, asking if it originated from North America or international markets like Europe.

    Answer

    CEO Arun Menawat and CFO Rashed Dewan confirmed that the capital sale was in North America, as detailed in the financial statements' segment report.

    Ask Fintool Equity Research AI